Related references
Note: Only part of the references are listed.Gemifloxacin once daily for 5 days versus 7 days for the treatment of community-acquired pneumonia: a randomized, multicentre, double-blind study
Thomas M. File et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2007)
Levofloxacin 750-mg for 5 days for the treatment of hospitalized Fine Risk Class III/IV community-acquired pneumonia patients
Andrew F. Shorr et al.
RESPIRATORY MEDICINE (2006)
Single-dose azithromycin microspheres vs clarithromycin extended release for the treatment of mild-to-moderate community-acquired pneumonia in adults
MA Drehobl et al.
CHEST (2005)
Novel, single-dose microsphere formulation of azithromycin versus 7-day levofloxacin therapy for treatment of mild to moderate community-acquired pneumonia in adults
J D'Ignazio et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
Inhibition of daptomycin by pulmonary surfactant: In vitro modeling and clinical impact
JA Silverman et al.
JOURNAL OF INFECTIOUS DISEASES (2005)
Daptomycin: Another novel agent for treating infections due to drug-resistant gram-positive pathogens
CF Carpenter et al.
CLINICAL INFECTIOUS DISEASES (2004)
Clinical and bacteriological efficacy and safety of 5 and 7 day regimens of telithromycin once daily compared with a 10 day regimen of clarithromycin twice daily in patients with mild to moderate community-acquired pneumonia
G Tellier et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2004)
Share Paper
